INDOCOPharmaceuticals
Indoco Remedies Ltd — PE Ratio & Valuation Analysis
₹164.00
-6.69%
Current P/EN/AxPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E27.1x100.0% below avg
✅
100.0% Discount to Industry
INDOCO P/E N/Ax vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2024 | ₹10.51 | ₹332 | 31.6x |
| 2023 | ₹15.42 | ₹395 | 25.6x |
| 2022 | ₹16.80 | ₹407 | 24.2x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Indoco Remedies Ltd Valuation
Indoco Remedies Ltd (INDOCO) currently trades at N/Ax earnings. The Pharmaceuticals sector average PE is 31.77x. Historically, INDOCO has traded at an average PE of 27.1x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
-7.02%
Dividend Yield
0.08%
More on Indoco Remedies Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.